G25520XG

Summary
GlyTouCan ID
G25520XG
IUPAC Condensed
Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-4)][Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc(b1-
Motifs
N-Glycan complex N-acetyllactosamine Type 2 LN
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
1989.73
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying 1 entry
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
FUT10 GDP-Fuc
G25520XG
R
G95617FJ
R
Displaying 1 entry
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
FUT10 GDP-Fuc
G25520XG
R
G95617FJ
R
KEGG BRITE Database
KEGG ID
GALAXY
Glucose Units
ODS
20.2
Amide
7.5
Degrading Enzymes
Displaying entries 1 - 5 of 8 in total
Enzyme Substrate Product
α-Fucosidase
G25520XG
G52934AK
α-Galactosidase
G61684ET
G25520XG
α-Sialidase
G94045IP
G25520XG
α-Sialidase
G14127XU
G25520XG
α-Sialidase
G91023GB
G25520XG
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:b-dglc-HEX-1:5
4s:n-acetyl
5b:b-dman-HEX-1:5
6b:a-dman-HEX-1:5
7b:b-dglc-HEX-1:5
8s:n-acetyl
9b:b-dgal-HEX-1:5
10b:b-dglc-HEX-1:5
11s:n-acetyl
12b:a-dman-HEX-1:5
13b:b-dglc-HEX-1:5
14s:n-acetyl
15b:b-dgal-HEX-1:5
16b:a-lgal-HEX-1:5|6:d
LIN
1:1d(2+1)2n
2:1o(4+1)3d
3:3d(2+1)4n
4:3o(4+1)5d
5:5o(3+1)6d
6:6o(2+1)7d
7:7d(2+1)8n
8:7o(4+1)9d
9:5o(4+1)10d
10:10d(2+1)11n
11:5o(6+1)12d
12:12o(2+1)13d
13:13d(2+1)14n
14:13o(4+1)15d
15:1o(6+1)16d
WURCS
WURCS=2.0/5,11,10/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5][a2112h-1b_1-5][a1221m-1a_1-5]/1-1-2-3-1-4-1-3-1-4-5/a4-b1_a6-k1_b4-c1_c3-d1_c4-g1_c6-h1_d2-e1_e4-f1_h2-i1_i4-j1
Literature
Displaying entries 31 - 40 of 44 in total
PubMed ID Title First Author Publication Date Source
7686446 Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas Yamashita K 1993 Jul 01
  • GlyGen
  • PubChem
8274017 Structural Study of the Sugar Chains of Porcine Factor VIII - Tissue- and Species-Specific Glycosylation of Factor VIII Hironaka T 1993 Dec
  • GlyGen
  • PubChem
8299354 Comparative studies of asparagine-linked sugar chains of immunoglobulin G from eleven mammalian species Hamako J 1993 Dec
  • GlyGen
1456441 N-glycosylation site mapping of human serotransferrin by serial lectin affinity chromatography, fast atom bombardment-mass spectrometry, and 1H nuclear magnetic resonance spectroscopy Fu D 1992 Oct
  • GlyGen
  • PubChem
1577715 Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures Matsui T 1992 May 05
  • GlyGen
  • PubChem
1555586 Structure of the N-linked oligosaccharides of the human transferrin receptor ORBERGER G 1992 Apr 01
  • GlyGen
  • PubChem
1898343 Carbohydrate structure of human pancreatic elastase 1 Wendorf P 1991 Sep 01
  • GlyGen
  • PubChem
1841682 Structures of asparagine-linked oligosaccharides from hen egg-yolk antibody (IgY). Occurrence of unusual glucosylated oligo-mannose type oligosaccharides in a mature glycoprotein Ohta M 1991 Oct
  • GlyGen
1694115 Unique structure of glycopeptide from alpha-fetoprotein produced in human hepatoma cell line, as determined by 1H-nuclear magnetic resonance spectroscopy Terrana B 1990 Jun
  • GlyGen
  • PubChem
2363690 A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins Jefferis R 1990 Jun 15
  • GlyGen
  • PubChem

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.2.1

Last updated: April 7, 2025